G0S2, the endogenous inhibitor of ATGL, is epigenetically methylated in several cancers [28], has been considered to function as a tumor suppressor [37] and is markedly down-regulated in DAKO adipose tissue and DAKO liposarcoma. Here, G0S2 is linked to cancer.